Antitrust Policy, Patents, Pharmaceutical Drugs Flashcards
What are the antitrust laws in the US?
Sherman Act and Clayton Act
What is Sherman Act section 1?
covers conspiracies; contracts, combinations that are anticompetitive; agreements among firms to restrict competition; must include 2 firms making decisions together
What is the Sherman Act Section 2?
covers monopolization or intent to monopolize; being of a monopoly does not alone offend the antitrust laws; punishes illegally obtained monopolies, not aggressive competition or more efficient competitors
What is the Clayton Act?
prohibits certain business practices such as price discrimination, exclusionary practices, and mergers
Who are the enforcers of antitrust laws?
Antitrust Division of DOJ and FTC
What are antitrust issues in health care settings?
monopolies, monopsonies, collusion, mergers, etc
Patent
a patent is a device intended to explicitly give an inventor a property right over its discovery
What are the requirements to qualify for patents
patentable subject matter, novelty, utility, non obvious
What is the purpose of a patent?
encourage/stimulate research, development, and innovation
What are the benefits of being a patent holder?
the right to exclude all others from making, using, or selling for 20 years from the date their application was filed
What is the FDA approval process?
Phase I, Phase II, Phase III, FDA reviews application and grants approval if warranted
Phase I of patent approval
small human trial to establish drug safety
Phase II of patent approval
larger human trial; evaluate safety and effectiveness over longer time period
Phase III of patent approval
even larger human trial
Are prescription drugs the highest expenditure in US healthcare?
No, they just receive much of the media attention
What is the spending on prescription drugs?
~$370B
Why does the US spend more on prescription drugs than other OECD countries?
lack of health systems/regulatory systems, patent policy, inelastic demand, availability of substitutes, role of insurance (asymmetric info), new developments